Moreover, cannabigerol (CBG), a non-psychotropic cannabis-derived cannabinoid, used at 10 μM, potently blocks TRPM8 in CRC and protects against cancer development and progression [55]. This evidence concerns the gene TRPM8 and colorectal carcinoma.